Decoy Therapeutics, Inc. (DCOY)
2.74
-0.14
(-4.86%)
USD |
NASDAQ |
Sep 04, 16:00
2.74
0.00 (0.00%)
After-Hours: 19:33
Decoy Therapeutics Cash from Investing (Quarterly) : -0.0424M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0424M |
| March 31, 2026 | 0.00 |
| December 31, 2025 | 0.9647M |
| September 30, 2025 | -0.20M |
| June 30, 2025 | 0.00 |
| March 31, 2025 | 0.00 |
| December 31, 2024 | 0.00 |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -0.0026M |
| September 30, 2020 | 0.00 |
| Date | Value |
|---|---|
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 5.608M |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | -14.12M |
| June 30, 2018 | 2.001M |
| March 31, 2018 | 12.12M |
| December 31, 2017 | 4.662M |
| September 30, 2017 | -10.80M |
| June 30, 2017 | 23.74M |
| March 31, 2017 | 6.881M |
| December 31, 2016 | 0.885M |
| September 30, 2016 | -3.874M |
| June 30, 2016 | -5.731M |
| March 31, 2016 | -3.521M |
| December 31, 2015 | -17.04M |
| September 30, 2015 | -10.15M |
| June 30, 2015 | -0.0492M |
| March 31, 2015 | -0.0264M |
| December 31, 2014 | -0.017M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Palatin Technologies, Inc. | -0.0385M |
| Unicycive Therapeutics, Inc. | -0.023M |
| Nuvectis Pharma, Inc. | 0.00 |
| ACADIA Pharmaceuticals, Inc. | -8.529M |
| Alnylam Pharmaceuticals, Inc. | -363.46M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.652M |
| Cash from Financing (Quarterly) | 3.163M |
| Free Cash Flow | -8.367M |
| Free Cash Flow Per Share (Quarterly) | -5.065 |
| Free Cash Flow to Equity (Quarterly) | -2.694M |
| Free Cash Flow to Firm (Quarterly) | -2.694M |
| Free Cash Flow Yield | -746.6% |